Millie
your market intelligence analyst
Search Results
246 results
Your search is now limited to «Atrial Fibrillation» expert search.
The study will evaluate the performance of the investigational TactiFlex™ Ablation Catheter, Sensor Enabled™ (SE) for people whose atrial fibrillation (AFib) symptoms are unable to be managed by medication.
More from Healthcare Sales & Marketing Network:
ClinicalTrials.gov 08/04/2020 07:26
Conditions : Persistent Atrial Fibrillation; Catheter Ablation Interventions : Procedure: upgraded '2C3L'; Procedure: pulmonary vein antral isolation Sponsors : Beijing Anzhen Hospital; Heart Health Research Centre; The George Institute for Global Health, China; The George Institute for Global Health, Australia; Fukuoka University Not yet recruiting.
More from ClinicalTrials.gov:
News-Medical.net 08/04/2020 01:06
Another study involves patients with hypertension and other cardiovascular conditions who are taking two types of medications: angiotensin converting enzyme inhibitors (ACE-I) or angiotensin receptor blockers (ARB.
More from News-Medical.net:
FeedNavigator (EU) 08/03/2020 15:03
Furthermore, the connection between type 2 diabetes and heart failure [7], and increased risk of cardiovascular disease [8] is well established.
More from FeedNavigator (EU):
DoctorsLounge 08/03/2020 13:00
For patients undergoing atrial fibrillation ablation, higher cardiorespiratory fitness is associated with reduced arrhythmia recurrence rates and death, according to a study published online Aug. 3 in Heart Rhythm.
More from DoctorsLounge:
Cardiovascular Diabetology 08/02/2020 20:00
CD14 ++CD16 + monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
More from Cardiovascular Diabetology:
EurekAlert 07/27/2020
Although it's more common with advancing age, in the patients with chronic heart conditions, often post-surgically, there is still a lot unknown about the cellular mechanisms that initiate or sustain atrial fibrillation, especially in the early stages before there's been time for extensive tissue fibrosis (scarring.
More from EurekAlert:
Mini-Sentinel 07/27/2020
Many studies showing underuse of oral anticoagulants (OACs) in patients with atrial fibrillation (AF) predated the advent of the non-vitamin K antagonist OACs. We retrospectively examined use of OACs in a large commercially insured population.
Real-World Analysis of Potential Pharmacokinetic and Pharmacodynamic Drug Interactions with Apixaban in Patients with Non-Valvular Atrial Fibrillation.
More from International Journal of COPD:
Healio News 07/21/2020 17:20
Back to Healio The FDA has approved a second-generation left atrial appendage closure device for patients with nonvalvular atrial fibrillation, Boston Scientific announced.
More from Healio News:
MedicalDeviceLink.com 07/20/2020 15:24
Cardiva Medical has enrolled the first patients in a multi-center study designed to evaluate same-day discharge for patients undergoing cardiac ablation procedures for atrial fibrillation.
More from MedicalDeviceLink.com:
Large corporations like FitBit and Apple are entering the medical domain with consumer wearable devices, most prominent through automated activity measures like step count [,] to support disease monitoring and rehabilitation of cardiac, pulmonary, and cancer patients [,-], among others, and most recently, through large-scale interventions using the Apple Watch for screening of atrial fibrillation.
More from Journal of Medical Internet Research:
This randomized clinical trial assesses the use of a shared decision-making tool during clinical encounters and the effects on anticoagulant treatment decisions in patients with atrial fibrillation who are at risk of experiencing stroke.
More from Archives of Internal Medicine - Abstracts:
Business Wire 07/15/2020 11:41
Vivasc’s proprietary Cardiac Targeting Peptide (CTP) has been shown to deliver therapeutic cargo (oligonucleotides, peptides, proteins, nanoparticles, etc.) to cardiomyocytes.
More from Business Wire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications